Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W MAAS

Showing results (21-30 of 148) with videos related to

Pageof 15
Sort By:
European Journal of Pharmacology|November 5, 1981
D-Amphetamine at low doses suppresses noradrenergic functionsY H Huang, J W Maas
Brain Research|October 8, 1976
Stimulation of the dorsal noradrenergic dundle and field potentials in the locus coeruleusY H Huang, J W Maas
Biological Psychiatry|April 15, 1992
Neurobiology and psychopathological states: are we looking in the right place?J W Maas, M M Katz
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 1, 1994
Psychopharmacology and the etiology of psychopathologic states: are we looking in the right way?M M Katz, J W Maas
Journal of Neural Transmission|January 1, 1977
A study of the formation and metabolic disposition of 3,4 dihydroxyphenylethyleneglycol in whole rat brainS W Gale, J W Maas
Nature|April 2, 1971
Catecholamine metabolism, depression and stressJ W Maas, H Dekirmenjian, J Fawcett
Psychopharmacology Communications|January 1, 1976
The occurrence of free vs. conjugated MHPG in non-human and human primate brainJ W Maas, H Landis, H Dekirmenjian
Archives of General Psychiatry|March 1, 1972
Catecholamine metabolism, depressive illness, and drug responseJ W Maas, J A Fawcett, H Dekirmenjian
Life Sciences|October 10, 1975
Blood-brain barrier to 6-hydroxydopamine: uptake by heart and brainD L Garver, J Cedarbaum, J W Maas
Toxicology and Applied Pharmacology|November 11, 1975
Cardiovascular effects of D,L-threo-dihydroxyphenylserine in catsD E Redmond, R Olander, J W Maas
Pageof 15

Showing results (21-30 of 148) with videos related to

Sort By:
Pageof 15
European Journal of Pharmacology|November 5, 1981
D-Amphetamine at low doses suppresses noradrenergic functionsY H Huang, J W Maas
Brain Research|October 8, 1976
Stimulation of the dorsal noradrenergic dundle and field potentials in the locus coeruleusY H Huang, J W Maas
Biological Psychiatry|April 15, 1992
Neurobiology and psychopathological states: are we looking in the right place?J W Maas, M M Katz
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 1, 1994
Psychopharmacology and the etiology of psychopathologic states: are we looking in the right way?M M Katz, J W Maas
Journal of Neural Transmission|January 1, 1977
A study of the formation and metabolic disposition of 3,4 dihydroxyphenylethyleneglycol in whole rat brainS W Gale, J W Maas
Nature|April 2, 1971
Catecholamine metabolism, depression and stressJ W Maas, H Dekirmenjian, J Fawcett
Psychopharmacology Communications|January 1, 1976
The occurrence of free vs. conjugated MHPG in non-human and human primate brainJ W Maas, H Landis, H Dekirmenjian
Archives of General Psychiatry|March 1, 1972
Catecholamine metabolism, depressive illness, and drug responseJ W Maas, J A Fawcett, H Dekirmenjian
Life Sciences|October 10, 1975
Blood-brain barrier to 6-hydroxydopamine: uptake by heart and brainD L Garver, J Cedarbaum, J W Maas
Toxicology and Applied Pharmacology|November 11, 1975
Cardiovascular effects of D,L-threo-dihydroxyphenylserine in catsD E Redmond, R Olander, J W Maas
Pageof 15